54
Chinmedomics strategy for discovery of effective constituents from traditional herbal medicine Satyender Kumar Department of Natural Products

Chinmedomics in drug discovery

Embed Size (px)

Citation preview

Page 1: Chinmedomics in drug discovery

Chinmedomics strategy for discovery of effective constituents from traditional herbal medicine

Satyender KumarDepartment of Natural Products

Page 2: Chinmedomics in drug discovery

The World Health Organization (WHO) has recently defined traditional medicine (including herbal drugs) as comprising therapeutic practices that have been in existence, often for hundreds of years, before the development and spread of modern medicine and are still in use today.

Traditional Herbal Medicine (THM)

Current Science, Vol. 78, No. 1, 10 January 2000

Herbs

•Crude plant material such as leaves, flowers, fruit, seed, stems,

wood, bark, roots, rhizomes or other plant parts, which may be

entire, fragmented or powdered.

Herbal materials

•Fresh juices, gums, fixed oils, essential oils, resins and

dry powders of herbs.

Herbal preparations

•Powdered herbal materials, or extracts, tinctures and

fatty oils of herbal materials.

Finished herbal

products

•Finished herbal products and mixture herbal products may

contain excipients in addition to the active ingredients, finished

products or mixture products to which chemically defined active

substances have been added.

Herbal medicine

Page 3: Chinmedomics in drug discovery

The earliest recorded evidence of their use in Indian, Chinese, Egyptian, Greek,

Roman and Syrian texts dates back to about 5000 years.

Herbal medicines (HM) have been widely used for their antibacterial, antifungal,

anticancer, antiviral, and anti-inflammatory activities, and other pharmacological

activities.

Traditional Chinese medicine (TCM) has its own unique medical system with the

significant characteristics of pursuing an overall therapeutic effect with a multi-

target treatment.

It consists of multiple plants (called ‘formulae or prescription’) that could regulate

balance and homeostasis of the body in a holistic fashion.

Why herbal medicine?

Current Science, Vol. 78, No. 1, 10 January 2000

Page 4: Chinmedomics in drug discovery

HM are not pure products with a single active ingredient. Therefore, conventional

methods for screening and identifying the active ingredients in natural products

are time-consuming and labour intensive.

Traditional natural product discovery, using conventional methods, affords no

information about mode of action until late in the discovery process. This leads to

high rates of rediscovery and low probabilities of finding compounds with unique

biological properties.

Need some update in herbal medicine?

Currently, HM development has been hampered due to the lack of high

throughput, rapid methods for screening and identifying bioactive constituents.

Therefore, it is essential to develop a method able to overcome these

limitations.

OMICS A Journal of Integrative Biology Volume 16, Numbers 7 and 8, 2012

Page 5: Chinmedomics in drug discovery

Syndrome Formulae Effectiveness of Herbal medicine

Components of TCM

•TCM is so complicated that it’s almost impossible to explore the molecular mechanism and

effective substances thoroughly.

•Moreover, compounds in TCM exert therapeutic effects in combination rather than as

individuals.

Page 6: Chinmedomics in drug discovery

TCM treatment with therapeutic strategies in holistic fashion is focuses on the

patient rather than disease, promoting enhancing the quality of life.

From the point of modern system medicine, TCM syndrome is a functional state

that caused by the body’s metabolic imbalances.

Syndrome is a basic description of the disease in TCM, due to lack of objective

criteria for syndrome diagnostics, and thus it is difficult to properly evaluate the

efficacy of formulae.

TCM Syndrome

Current Science, Vol. 78, No. 1, 10 January 2000

Page 7: Chinmedomics in drug discovery

Cinmediformulae

Page 8: Chinmedomics in drug discovery

Cinmediformulae

Formulae include four elements:

the monarch (which plays the most

important role in the formulae),

the minister (which increases the

effectiveness of the monarch herb),

the assistant (which helps the monarch and minister herbs reach their target positions)

the servant (which can reduce the adverse effects and/or increase

the potency of the whole formulae)

Page 9: Chinmedomics in drug discovery

Cinmediformulae

• Practitioners often prescribe a combination of herbs called formulae based on

an over-all symptoms and signs of syndrome, and work together harmoniously

to achieve ideally therapeutic effects.

• Single herb already contains thousands of compounds, formulae consisting of

multi-herb has become the chemical composition giant system.

• That means to say, the efficacy of TCM depends on the combined action of

multiple herbs because it usually contains a lot of ingredients and exert

synergistic therapeutic efficacies.

• However, this can cause many difficulties in the search for the effective

substances of TCM.

Page 10: Chinmedomics in drug discovery

Difficulties of TCM

Lack of a comprehensive

understanding of the relationship

between syndrome and formulae,

For TCM to be modernized, it is

critical to use modern tools to

determine the mechanism of action

of TCM.

Process and leads to low

probabilities of finding compounds

with unique biological properties.

Page 11: Chinmedomics in drug discovery

New tools and methods help revive ancient traditional Chinese medicine

A new platform, termed chinmedomics which is capable of directly

discover the bioactive constituents from herbal medicine.

It is base upon an analyzing the correlation between the endogenous

biomarker of diseases or TCM syndrome and exogenous constituents to

find the highly associated constituents with efficacy of formulae as the

effective substances.

Further clarifying the activities of effective substances, and may discover

lead compounds and make the innovative drug discovery based on clinical

experiences. It will significantly advance the drug discovery from

traditional medicine.

Page 12: Chinmedomics in drug discovery

Key points in Chinmedomics

Serum Pharmacoche

mistry of TCM (SPT)

• providing methodology for the discovery of

active constituents in vivo from TCM, solving

the efficacy and effectiveness of TCM

Metabolomics technology

• is used to clarify the molecular mechanisms of

syndrome.

Screening of active

constituents

• using the plotting of correlation between

(endogenous) marker metabolites and

(exogenous) serum constituents, and is ongoing

verification by further biological experiments.

Correlation analysis

•between the exogenous compounds in vivo after oral

formulae and endogenous marker metabolites in vivo

are used to clarify the effective substances and their

synergistic properties.

Page 13: Chinmedomics in drug discovery

After being metabolized by the liver and gastrointestinal tract, the components

that finally reach the blood are usually not the original ingredients, and there are

also some metabolism ingredients.

The blood contained, ingredients may be the substances playing a direct role in the

body.

Research on the components in the serum could be an effective approach to

identify the effective substances of TCM.

To resolve these problems, in early 1990s, we firstly established the SPT that can

reflect drug action, absorption, distribution and interaction in the body.

Serum pharmacochemistry of TCM

Page 14: Chinmedomics in drug discovery

Metabolomics and related metabonomics approach is a specific ‘top-down’

systems biology manifestation of metabolic profiling of small-molecule metabolites

have an important role in biological systems

Metabolomics can capture information with regard to mechanisms of disease and

drug action.

Samples of interest (e.g., plasma, urine, cerebral spinal fluid, or tissue biopsies) are

collected. Blood samples are the most commonly collected biological fluid,

providing a representation of the global metabolome.

Metabolomics: an overview

such as lipids, amino acids, peptides, nucleic acids, and organic acids, vitamins,

thiols, carbohydrates, etc, and represent attractive candidates to understand

disease phenotypes.

Page 15: Chinmedomics in drug discovery

Figure: The overall procedure of chinmedomics analysis. Chinmedomics technology consists of three sequential steps: (1) an experimental technique, based on MS or NMR spectroscopy, designed to profile endogenous low-weight metabolites, (2) multivariate data analysis using bioinformatics techniques, and (3) metabolites identification and quantification resulting in biomarkers (UPLC-ESI-MS, ultra-performance liquid chromatography/electrospray ionization/mass spectrometry; TIC, total ion chromatogram).

Metabolomics: an overview

Page 16: Chinmedomics in drug discovery

Potential biomarkers which are very useful for diagnosing and monitoring disease

progress, were extracted from loading-plots constructed following the PLS-DA

(Partial Least Square- Data Analysis), and biomarkers were chosen based on their

contribution to the variation and correlation within the data set.

Page 17: Chinmedomics in drug discovery

Figerprinting of biomarkers from urine sample

Page 18: Chinmedomics in drug discovery

Figure: Typical metabolomics experiment flow diagram. Samples are analysed by full scan profile to collect all metabolites. Pattern recognition approach aims to highlight underlying trends. Receiver operating characteristic curves are generally considered the method of choice for evaluating the performance of potential biomarkers. The markers are eventually placed in metabolic pathway to provide insight on the biochemical phenomena.

Page 19: Chinmedomics in drug discovery

Case study

Page 20: Chinmedomics in drug discovery

Case study

SQW was selected for the bioactive constituents analysis in the treatment of SYX by using

chinmedomics strategy.

Shan Qi Wan (SQW) is a typical TCM formula consisting of Radix rahmanniae preparata, Fructus

macrocarpii, Rhizoma dioscoreae, Rhizoma zlismatis, Poaria, Cortex moutan radicis, Radix aconiti

lateralis preparata and Rahmulus cinnamomi was selected.

These 23 metabolites were found involved in multiple biochemical processes such as: energy

metabolism, lipid metabolism and amino acid metabolism

23 endogenous urinary metabolites of rat perturbed after treatment of hydrocortisone were measured

by using metabolomics

Shen Yang Xu (SYX, Kidney-yang deficiency syndrome) was produced by high doses of Hydrocortisone

Page 21: Chinmedomics in drug discovery

Experimental work

1. Preparation of SQW samples

2. Animal handling

3. Sample collection and preparation

4. Metabolomics study

a. UPLC analysis

b. MS analysis

c. Metabolic analysis

5. Constituent analysis

6. Correlation analysis of marker metabolites and absorbed constituents

7. Potential target prediction of highly correlated ingredients

Page 22: Chinmedomics in drug discovery

SQW powder was dissolved in distilled water to form a stock solution (0.3389 g/ml).

The freeze-dried powder was dissolved in water to make 1.08 g/ml solutions.

then ground, mixed and reflux extracted in a rotary evaporator with six times of 100%

methanol for 2 hr. Then the filtrate was freeze dried.

Shan Qi Wan (SQW) is a typical TCM formula consisting of Radix rahmanniae preparata,

Fructus macrocarpii, Rhizoma dioscoreae, Rhizoma zlismatis, Poaria, Cortex moutan radicis,

Radix aconiti lateralis preparata and Rahmulus cinnamomi in proportion of (8: 4: 4: 3: 3: 3: 1:

1)

1. Preparation of SQW samples

Page 23: Chinmedomics in drug discovery

Male Wistar rats (200-249 g)

• Conditions: 21 ± 5 C with 60 ± 5% relative humidity, 12 h light-dark cycle ⁰withstandard diet and water.

• Dose: 1 ml/100 g body mass of SQW solution (0.3389 g/ml).

Groups: (15 rats in each group)

• Control group (olive oil injected i.p. for 21 consecutive days)

• Model group (corticosterone injected i.p. at 10 mg/kg for 21 consecutive days

• SQW group (corticosterone injected i.p. at 10 mg/kg for 21 consecutive days +

after that an accurate volume of SQW for consecutive 15 days)

2. Animal handling

Page 24: Chinmedomics in drug discovery

The mixture solution was filtered through a 0.22 mm PTFE membrane and

transferred to vials for UPLC/MS analysis.

Supernatants were dried under nitrogen and redissolved with 80% methanol to

volumes of 200 µl.

After vortexing for 10 s, supernatants (800 µl) were collected after centrifugation

13,000 rpm for 10 minutes.

The supernatant was collected and stored at -80 C before analysis.⁰

Serum and plasma were separated by centrifugation at 4000 rpm for 10 minutes at 4

C after standing for 30 minutes.⁰

Blood was collected from abdominal aorta

3. Sample collection and preparation

Page 25: Chinmedomics in drug discovery

Metabolite analysisMS data acquired were performed to Markerlynx within

Masslynx software (version 4.1) for detection and alignment.

The multivariate data matrix was input to Ezinfo Ver. 2.0 software for Principal component analysis (PCA), Partial least

square discriminant analysis (PLS-DA) and orthogonal projection to latent structures (OPLS) analysis.

MS analysis

Mass spectrometer was connected to UPLC system via an electrospray ionization (ESI) interface.

UPLC analysis

HSS T3 column was used Acetonitrile with 0.1% formic acid and water with 0.1% formic acid at flow rate 0.4 ml/min and injection volume was 3 µl.

4. Metabolomics study

Page 26: Chinmedomics in drug discovery

Correlation analysis of marker metabolites and

absorbed constituents• A plot of correlation between marker metabolites and chemical composition was

used to screen the constituents or metabolites absorbed in to blood after oral

administration.

Page 27: Chinmedomics in drug discovery

Potential target prediction of highly correlated

ingredients• The target numbers were entered into the KEGG database (

http://www.genome.jp/kegg/) to annotate and analysis the pathway.

Page 28: Chinmedomics in drug discovery

Results

Page 29: Chinmedomics in drug discovery

Figure: Base peak ion chromatograms of plasma samples in UPLC/QTOF MS analysed by MarkerLynx software

(A) control group

(B) model group

(C) SQW group

% Intensity

Time

Base peak intensity (BPI) chromatgrams of biosamples

Page 30: Chinmedomics in drug discovery

(A), Score plots of PCA based on serum metabolite profiling

Multivariate data analyses of the UPLC/MS serum spectra data of control and model group

Control group Model group

Page 31: Chinmedomics in drug discovery

(B), The S-plot of PLS-DA for the control and model groups.

Multivariate data analyses of the UPLC/MS serum spectra data of control and model group

Page 32: Chinmedomics in drug discovery

Relative signal intensities of serum metabolites identified by UPLC/MS

Page 33: Chinmedomics in drug discovery
Page 34: Chinmedomics in drug discovery

The 3-d PCA plot for SQW treatment on SYX (control group; ■, model group; , SQW group)

Control group Model group SQW treated group

Page 35: Chinmedomics in drug discovery

ESI base peak ion chromatogram of the SQW analysed by UPLC/QTOF MS in negative ion mode (A) and positive ion mode (B).

Base peak intensity (BPI) chromatgrams of biosamples

Page 36: Chinmedomics in drug discovery

Extracted ions chromatogram of rat serum after oral administration of SQW with Metabolynx™ in negative ion mode (A) and positive ion mode (B). The peak numbers are

listed in Table S4 and S5.

Extracted ions chromatogram

Page 37: Chinmedomics in drug discovery

Correlation between marker metabolites and serum constituents in SQW. The correlation coefficients are listed in Table S6.

Highly positively correlatedhighly negatively correlatedlow correlation

Page 38: Chinmedomics in drug discovery

left column: chemical components top column: marker metabolites

Highly positively correlatedhighly negatively correlatedlow correlation

Page 39: Chinmedomics in drug discovery

Overview of chinmedomics

A schematic diagram of the Chinmedomics-based investigation into the molecular mechanisms and effective substances of syndrome and formulae by integratingSerum Pharmacochemistry of TCM and metabolomics analysis.

Page 40: Chinmedomics in drug discovery

Conclusion

• 23 biomarkers were identified for KYX syndrome and out of these 5 were up-regulated and 18

were down regulated.

• 84 compounds were identified or tentatively characterized from the constituents of SQW and

out of 84 compounds 51 were found in positive ion mode and 33 were found in negative ion

mode.

• The extracted ions cromatogram of plasma samples with the MetabolynxTM were separated

using UPLC method.

• 20 compounds out of absorbed constituents of SQW were highly correlated with the effect of

SQW.

Page 41: Chinmedomics in drug discovery

Thank You for your time today!

Questions?

Page 42: Chinmedomics in drug discovery

Theory of yin-yang

Page 43: Chinmedomics in drug discovery

Initially, yin and yang refer to the light and darkness of the sunlight, anything that is exposed to the sun belongs to yang, and that is unexposed to the sun belongs to yin.

Page 44: Chinmedomics in drug discovery

Some examples for Yin-yang properties of things

• Yang----Heaven, big, sun, day, fire, upward, active, male, Spring and Summer, warm, bright, function, et. al.

• Yin----Earth, small, moon, night, water, downward, still, female, Autumn and Winter, cold, dim, material et. al.

Page 45: Chinmedomics in drug discovery

In medical field

Any materials and functions which have the feature of promoting,

warming or exciting

Any materials and functions which have the feature of coagulating,

moistening and inhibiting

Yang

Yin

Page 46: Chinmedomics in drug discovery

Relativity of yin and yang

e.g. Human body viscera

Yang back fu organs

Yin Chest and abdomen zang organs

Page 47: Chinmedomics in drug discovery

Application of theory of yin and yang in TCM

(1) To explain morphology and structure of the human body

e.g. chest and abdomen, lower part, yin meridians, blood……. back, upper part, yang meridians, qi……

(2) To explain physiological functions of the human body

e.g. Yin qi

Yang qi

Page 48: Chinmedomics in drug discovery

Application of theory of yin and yang in TCM

preponderance of yin or yang

decline of yin or yang

simultaneous of yin and yang

inter-transformation and repelling of yin and yang

(3) To explain pathological changes of the human body

Page 49: Chinmedomics in drug discovery

Application of theory of yin and yang in TCM

(4) To guide clinical diagnosis

It is to differentiate yin or yang properties of a certain syndrome

(5) To treat diseases

e.g. To determine the therapeutic

principles

To generalize properties and actions of Chinese drugs

Reducing excess

Supplementing insufficiency

Page 50: Chinmedomics in drug discovery
Page 51: Chinmedomics in drug discovery
Page 52: Chinmedomics in drug discovery
Page 53: Chinmedomics in drug discovery

UPLC-HDMS chromatograms of SQW in negative ion mode. The peak numbers are listed in Table S2. (A), in vitro; (B), dosed serum; (C), control serum.

Page 54: Chinmedomics in drug discovery

UPLC-HDMS chromatograms of SQW in positive ion mode. The peak numbers are listed in Table S2. (A), in vitro; (B), dosed serum; (C), control serum.